Back to News
Market Impact: 0.42
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 20, 2026 in Fractyl Health, Inc. Lawsuit
Source: GlobeNewswire
Legal & LitigationHealthcare & BiotechManagement & GovernanceCompany Fundamentals
Fractyl Health CEO Harith Rajagopalan and former CFO Lisa A. Davidson face Section 20(a) control-person claims tied to allegations that Revita DMR efficacy data was overstated. GUTS shares lost approximately 74.86% over two trading days, signaling severe investor concern over the company's clinical-data disclosures and governance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.78
Ticker Sentiment
GUTS-0.95
More News
- Nasdaq Nears Correction as Amazon, Alphabet, Intel Disappoint Wall Street
- Binance’s $6.3 Billion Cyber Heist Shows Crypto Vulnerabilities
- Intel’s stock crashes, knocking $12B from government’s stake
- Chevron speeds ahead in Venezuela while Exxon urges caution with a ‘little pinch of salt’
- Backbone of a beast – charting Nvidia's rise to networking titan
- OpenAI raises just $11bn of $30bn target as AI investor appetite cools